$KRYS insiders have traded $KRYS stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales. Here’s a ...
Shares of Krystal Biotech KRYS have surged 57.2% in a year compared with the industry’s growth of 17.1%. The stock has also outperformed the industry and the sector in this time frame. The strong ...
Fintel reports that on July 1, 2025, Clear Street initiated coverage of Krystal Biotech (NasdaqGS:KRYS) with a Buy recommendation. Analyst Price Forecast Suggests 50.55% Upside As of June 20, 2025, ...
Hosted on MSN
Vyjuvek growth powers Krystal Biotech’s (KRYS) huge upward analyst target price revision
Krystal Biotech, Inc. (NASDAQ:KRYS) is one of the 10 best NASDAQ growth stocks to buy for the next 10 years. Andrea Tan, an analyst at Goldman Sachs, raised the firm’s price target on Krystal Biotech, ...
The average one-year price target for Krystal Biotech (NasdaqGS:KRYS) has been revised to $269.93 / share. This is an increase of 18.96% from the prior estimate of $226.90 dated December 18, 2025. The ...
Krystal Biotech (KRYS) has drawn fresh attention after reporting positive interim data from the highest dose cohort of its Phase 1 CORAL-1 study of inhaled gene therapy KB407 in cystic fibrosis. See ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results